BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 22722313)

  • 1. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
    Shebl FM; Sakoda LC; Black A; Koshiol J; Andriole GL; Grubb R; Church TR; Chia D; Zhou C; Chu LW; Huang WY; Peters U; Kirsh VA; Chatterjee N; Leitzmann MF; Hayes RB; Hsing AW
    Br J Cancer; 2012 Jun; 107(1):207-14. PubMed ID: 22722313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.
    Johnson CC; Hayes RB; Schoen RE; Gunter MJ; Huang WY;
    Am J Gastroenterol; 2010 Dec; 105(12):2646-55. PubMed ID: 20808298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
    Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
    Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.
    Chudy-Onwugaje K; Huang WY; Su LJ; Purdue MP; Johnson CC; Wang L; Katki HA; Barry KH; Berndt SI
    Cancer; 2021 Sep; 127(17):3145-3155. PubMed ID: 33974712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
    Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
    Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
    Fowke JH; Motley SS; Smith JA; Cookson MS; Concepcion R; Chang SS; Byerly S
    J Urol; 2009 May; 181(5):2064-70. PubMed ID: 19286210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
    Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
    Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
    Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH;
    Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US.
    Habel LA; Zhao W; Stanford JL
    Cancer Causes Control; 2002 Jun; 13(5):427-34. PubMed ID: 12146847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
    Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
    Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
    Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Matchaba P; Gimona A; Hawkey CJ;
    Lancet; 2004 Aug 21-27; 364(9435):665-74. PubMed ID: 15325831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin use in relation to risk of prostate cancer.
    Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study.
    Nelson JE; Harris RE
    Oncol Rep; 2000; 7(1):169-70. PubMed ID: 10601612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.
    Salinas CA; Kwon EM; FitzGerald LM; Feng Z; Nelson PS; Ostrander EA; Peters U; Stanford JL
    Am J Epidemiol; 2010 Sep; 172(5):578-90. PubMed ID: 20688905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
    Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
    PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.
    Dasgupta K; Di Cesar D; Ghosn J; Rajan R; Mahmud S; Rahme E
    Cancer J; 2006; 12(2):130-5. PubMed ID: 16630404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.